Conaghan discussed the potential of StEPP as a measure in clinical trials.
Philip Conaghan, MBBS, PhD
Advertisement
Director of the NIHR Leeds Biomedical Research Centre; Prof of Musculoskeletal Medicine for University of Leeds, Honorary Consultant Rheumatologist for LTHT; NIHR Senior Investigator Emeritus
Articles by Philip Conaghan, MBBS, PhD
Conaghan discussed the potential of LEVI-04 for knee osteoarthritis at ACR 2025.
Conaghan discussed findings from the ENX-CL-05-001 phase 2a trial at the ACR Convergence.
Advertisement
Latest Updated Articles
Apoptotic Cell Therapy Shows Promising Benefits for Older Adults With Knee OA, with Philip Conaghan, MBBS, PhDPublished: October 26th 2025 | Updated:
LEVI-04 Improves Pain, Function in Knee Osteoarthritis, with Philip Conaghan, MBBS, PhDPublished: November 5th 2025 | Updated:
Objectively Measuring Pain and Function in Osteoarthritis, With Philip Conaghan, MBBS, PhDPublished: November 6th 2025 | Updated:
Advertisement
Advertisement